Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD)

Novartis Pharmaceuticals · 2009
ClinicalTrials.gov · Datasets · License: Public Domain · 2009
Open Source ↗
copd
chronic obstructive pulmonary disease (copd), respiratory, dyspnea, breathlessness, copd, indacaterol, long-acting β2-agonist, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 917088
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.